Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003154795 | SCV003843736 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246190 | SCV004093816 | uncertain significance | not specified | 2023-07-30 | criteria provided, single submitter | clinical testing | The p.R257K variant (also known as c.770G>A), located in coding exon 1 of the MLH3 gene, results from a G to A substitution at nucleotide position 770. The arginine at codon 257 is replaced by lysine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |